{"text": ["Johnson", "&", "Johnson", "to", "Host", "Investor", "Conference", "Call", "on", "Third-Quarter", "Results"], "created_at": "2018-09-19 20:57:00"}
{"text": ["5", "Dividend", "Stocks", "With", "50-Plus", "Years", "of", "Annual", "Dividend", "Hikes"], "created_at": "2018-09-19 20:46:35"}
{"text": ["5", "Dividend", "Stocks", "With", "50-Plus", "Years", "of", "Annual", "Dividend", "Hikes"], "created_at": "2018-09-19 20:46:35"}
{"text": ["Taking", "Stock", "of", "Quest", "Diagnostics\u2019", "Recent", "Acquisitions"], "created_at": "2018-09-19 18:52:39"}
{"text": ["How", "Quest", "Diagnostics", "Is", "Positioned", "in", "2018"], "created_at": "2018-09-19 18:52:38"}
{"text": ["J&J", "Files", "NDA", "for", "Erdafitinib", "in", "Urothelial", "Cancer", "Indication"], "created_at": "2018-09-19 16:46:34"}
{"text": ["J&J", "Files", "NDA", "for", "Erdafitinib", "in", "Urothelial", "Cancer", "Indication"], "created_at": "2018-09-19 16:46:34"}
{"text": ["J&J", "Files", "NDA", "for", "Erdafitinib", "in", "Urothelial", "Cancer", "Indication"], "created_at": "2018-09-19 15:05:03"}
{"text": ["Pharma", "Stocks:", "Pfizer\u2019s", "Revenue", "Trend", "and", "2018", "Estimates"], "created_at": "2018-09-19 14:30:18"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Johnson", "&", "Johnson's", "Generic", "Unit", "Files", "NDA", "For", "Urinary", "Tract", "Cancer", "Drug,", "G1", "Therapeutics", "Prices", "Offering"], "created_at": "2018-09-19 12:47:08"}
{"text": ["Aduro's", "Cancer", "Arm", "&", "Strong", "Collaborations", "Boost", "Growth"], "created_at": "2018-09-19 00:36:49"}
{"text": ["Aduro's", "Cancer", "Arm", "&", "Strong", "Collaborations", "Boost", "Growth"], "created_at": "2018-09-19 00:36:49"}
